17th Congress of ECCO: European Crohn’s and Colitis Organisation*

Download these slides for expert insights on key trials presented at ECCO 2022 and the impact the data will have in the management of patients with Crohn disease and ulcerative colitis.

Uma Mahadevan, MD Bruce E. Sands, MD, MS Released: May 6, 2022

Recent acceleration in the development of biologics and small-molecule inhibitors for patients with inflammatory bowel disease has led to an expanded and increasingly complex treatment landscape. Here’s my take.

Bruce E. Sands, MD, MS Released: May 13, 2022

In this webcast, expert faculty translate and discuss the most clinically significant data from ECCO 2022 into evidence-based management strategies for patients with Crohn disease and ulcerative colitis.

Uma Mahadevan, MD Bruce E. Sands, MD, MS Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Released: May 19, 2022 Expired: May 18, 2023